290 related articles for article (PubMed ID: 28860188)
1. Discovery of a highly selective chemical inhibitor of matrix metalloproteinase-9 (MMP-9) that allosterically inhibits zymogen activation.
Scannevin RH; Alexander R; Haarlander TM; Burke SL; Singer M; Huo C; Zhang YM; Maguire D; Spurlino J; Deckman I; Carroll KI; Lewandowski F; Devine E; Dzordzorme K; Tounge B; Milligan C; Bayoumy S; Williams R; Schalk-Hihi C; Leonard K; Jackson P; Todd M; Kuo LC; Rhodes KJ
J Biol Chem; 2017 Oct; 292(43):17963-17974. PubMed ID: 28860188
[TBL] [Abstract][Full Text] [Related]
2. Targeting the Hemopexin-like Domain of Latent Matrix Metalloproteinase-9 (proMMP-9) with a Small Molecule Inhibitor Prevents the Formation of Focal Adhesion Junctions.
Alford VM; Kamath A; Ren X; Kumar K; Gan Q; Awwa M; Tong M; Seeliger MA; Cao J; Ojima I; Sampson NS
ACS Chem Biol; 2017 Nov; 12(11):2788-2803. PubMed ID: 28945333
[TBL] [Abstract][Full Text] [Related]
3. Functional mimetic peptide discovery isolated by phage display interacts selectively to fibronectin domain and inhibits gelatinase.
Shoari A; Rasaee MJ; Kanavi MR; Daraei B
J Cell Biochem; 2019 Dec; 120(12):19699-19711. PubMed ID: 31270859
[TBL] [Abstract][Full Text] [Related]
4. Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9): the next decade.
Vandooren J; Van den Steen PE; Opdenakker G
Crit Rev Biochem Mol Biol; 2013; 48(3):222-72. PubMed ID: 23547785
[TBL] [Abstract][Full Text] [Related]
5. Biomolecular basis of matrix metallo proteinase-9 activity.
Swetha R; Gayen C; Kumar D; Singh TD; Modi G; Singh SK
Future Med Chem; 2018 May; 10(9):1093-1112. PubMed ID: 29676173
[TBL] [Abstract][Full Text] [Related]
6. Discovery of potent and specific inhibitors targeting the active site of MMP-9 from the engineered SPINK2 library.
Yano H; Nishimiya D; Kawaguchi Y; Tamura M; Hashimoto R
PLoS One; 2020; 15(12):e0244656. PubMed ID: 33373399
[TBL] [Abstract][Full Text] [Related]
7. Role of the hemopexin domain of matrix metalloproteinases in cell migration.
Dufour A; Sampson NS; Zucker S; Cao J
J Cell Physiol; 2008 Dec; 217(3):643-51. PubMed ID: 18636552
[TBL] [Abstract][Full Text] [Related]
8. Quest for selective MMP9 inhibitors: a computational approach.
Shaikh AS; Sethi A; Makhal PN; Rathi B; Kaki VR
J Biomol Struct Dyn; 2023; 41(24):15053-15066. PubMed ID: 36905674
[TBL] [Abstract][Full Text] [Related]
9. Matrix metalloproteinase-9 (MMP-9) and its inhibitors in cancer: A minireview.
Mondal S; Adhikari N; Banerjee S; Amin SA; Jha T
Eur J Med Chem; 2020 May; 194():112260. PubMed ID: 32224379
[TBL] [Abstract][Full Text] [Related]
10. Multiple receptor-ligand based pharmacophore modeling and molecular docking to screen the selective inhibitors of matrix metalloproteinase-9 from natural products.
Gao Q; Wang Y; Hou J; Yao Q; Zhang J
J Comput Aided Mol Des; 2017 Jul; 31(7):625-641. PubMed ID: 28623487
[TBL] [Abstract][Full Text] [Related]
11. A matrix metalloproteinase-9 activation cascade by hepatic stellate cells in trans-differentiation in the three-dimensional extracellular matrix.
Han YP; Yan C; Zhou L; Qin L; Tsukamoto H
J Biol Chem; 2007 Apr; 282(17):12928-39. PubMed ID: 17322299
[TBL] [Abstract][Full Text] [Related]
12. An integrated computational and experimental approach to gaining selectivity for MMP-2 within the gelatinase subfamily.
Fabre B; Filipiak K; Díaz N; Zapico JM; Suárez D; Ramos A; de Pascual-Teresa B
Chembiochem; 2014 Feb; 15(3):399-412. PubMed ID: 24449516
[TBL] [Abstract][Full Text] [Related]
13. Identification of matrix metalloproteinase inhibitors by chemical arrays.
Kawatani M; Fukushima Y; Kondoh Y; Honda K; Sekine T; Yamaguchi Y; Taniguchi N; Osada H
Biosci Biotechnol Biochem; 2015; 79(10):1597-602. PubMed ID: 25988721
[TBL] [Abstract][Full Text] [Related]
14. Discovery of Sulfated Small Molecule Inhibitors of Matrix Metalloproteinase-8.
Morla S; Desai UR
Biomolecules; 2020 Aug; 10(8):. PubMed ID: 32784891
[TBL] [Abstract][Full Text] [Related]
15. Small-molecule anticancer compounds selectively target the hemopexin domain of matrix metalloproteinase-9.
Dufour A; Sampson NS; Li J; Kuscu C; Rizzo RC; Deleon JL; Zhi J; Jaber N; Liu E; Zucker S; Cao J
Cancer Res; 2011 Jul; 71(14):4977-88. PubMed ID: 21646471
[TBL] [Abstract][Full Text] [Related]
16. Matrix Metalloproteinases (MMPs) in Targeted Drug Delivery: Synthesis of a Potent and Highly Selective Inhibitor against Matrix Metalloproteinase- 7.
Wang LL; Zhang B; Zheng MH; Xie YZ; Wang CJ; Jin JY
Curr Top Med Chem; 2020; 20(27):2459-2471. PubMed ID: 32703131
[TBL] [Abstract][Full Text] [Related]
17. Structural basis for potent slow binding inhibition of human matrix metalloproteinase-2 (MMP-2).
Rosenblum G; Meroueh SO; Kleifeld O; Brown S; Singson SP; Fridman R; Mobashery S; Sagi I
J Biol Chem; 2003 Jul; 278(29):27009-15. PubMed ID: 12679334
[TBL] [Abstract][Full Text] [Related]
18. Circular trimers of gelatinase B/matrix metalloproteinase-9 constitute a distinct population of functional enzyme molecules differentially regulated by tissue inhibitor of metalloproteinases-1.
Vandooren J; Born B; Solomonov I; Zajac E; Saldova R; Senske M; Ugarte-Berzal E; Martens E; Van den Steen PE; Van Damme J; Garcia-Pardo A; Froeyen M; Deryugina EI; Quigley JP; Moestrup SK; Rudd PM; Sagi I; Opdenakker G
Biochem J; 2015 Jan; 465(2):259-70. PubMed ID: 25360794
[TBL] [Abstract][Full Text] [Related]
19. Insight into the complex and dynamic process of activation of matrix metalloproteinases.
Kotra LP; Cross JB; Shimura Y; Fridman R; Schlegel HB; Mobashery S
J Am Chem Soc; 2001 Apr; 123(13):3108-13. PubMed ID: 11457021
[TBL] [Abstract][Full Text] [Related]
20. Matrix metalloproteinase-2 and -9 are activated in joint diseases.
Clegg PD; Carter SD
Equine Vet J; 1999 Jul; 31(4):324-30. PubMed ID: 10454092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
